230 related articles for article (PubMed ID: 4296871)
1. [Studies on safety tests of inactivated poliomyelitis vaccines. V. Pathomorphological changes in the CNS of rhesus monkeys (Macaca rhesus) and long-tailed monkeys (Cercopithecus aethiops) following intracerebral and intralumbar inoculation with inactivated poliovirus types I, II, and 3].
Unterharnscheidt F; Günther O; Hövel H; Burde K; Heber L
Zentralbl Bakteriol Orig; 1966 Jun; 200(2):150-66. PubMed ID: 4296871
[No Abstract] [Full Text] [Related]
2. [Studies on safety tests of inactivated poliomyelitis vaccines. IV. Comparative safety tests in rhesus monkeys and long-tailed monkeys (Cercopithecus aethiops)].
Günther O; Hövel H; von Mettenheim A; Burde K; Heber L; Unterharnscheidt F
Zentralbl Bakteriol Orig; 1966 Jun; 200(2):137-50. PubMed ID: 4296870
[No Abstract] [Full Text] [Related]
3. [Studies on safety tests of inactivated poliomyelitis vaccines. VI. On the effect of cortisone in monkey experiments].
Günther O; Unterharnscheidt F; Hövel H
Zentralbl Bakteriol Orig; 1966 Jun; 200(2):166-79. PubMed ID: 4967641
[No Abstract] [Full Text] [Related]
4. [On the neurovirulence test of poliomyelitis-live vaccine. IV. Pathomorphology of monkey poliomyelitis through neuropathogenic poliovirus type 3 (Saukett strain) after intralumbar injection in comparison to the attenuated poliovirus strains].
Unterharnscheidt F; Bonin O; Günther O; Heber L; Schmidt K; Schmidt I; von Mettenheim AE
Arch Psychiatr Nervenkr (1970); 1966; 208(1):13-23. PubMed ID: 4290952
[No Abstract] [Full Text] [Related]
5. Neurovirulence testing of oral poliovaccine in the rhesus monkey.
Arya SC
Indian J Pathol Microbiol; 1976 Jul; 19(3):185-94. PubMed ID: 186408
[No Abstract] [Full Text] [Related]
6. [On the neurovirulence test of poliomyelitis-live vaccine. 3. Pathomorphology of monkey poliomyelitis through attenuated polioviruses after intrathalamic infection under particular consideration of differences between virus types].
Unterharnscheidt F; Bonin O; Schmidt K; Schmidt I
Arch Psychiatr Nervenkr (1970); 1966; 208(1):1-12. PubMed ID: 4290953
[No Abstract] [Full Text] [Related]
7. [Ultrastructural changes in the central nervous system of monkeys in poliomyelitis].
Erman BA; Tulakina LG
Arkh Patol; 1976; 38(10):64-70. PubMed ID: 190980
[TBL] [Abstract][Full Text] [Related]
8. Neurovirulence test for oral live poliovaccines using poliovirus-sensitive transgenic mice.
Abe S; Ota Y; Koike S; Kurata T; Horie H; Nomura T; Hashizume S; Nomoto A
Virology; 1995 Feb; 206(2):1075-83. PubMed ID: 7856082
[TBL] [Abstract][Full Text] [Related]
9. [STUDIES ON TESTING THE SAFETY OF INACTIVATED POLIOMYELITIS VACCINES. II. SV 40 IN INACTIVATED POLIOMYELITIS VACCINES].
GUENTHER O; HOEVEL H; VON METTENHEIM
Zentralbl Bakteriol Orig; 1963 Dec; 190():445-65. PubMed ID: 14166424
[No Abstract] [Full Text] [Related]
10. Studies on the characteristics of poliovirus type 3. II. Characteristics of "hot" clones.
Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
Acta Virol; 1976 Oct; 20(5):366-72. PubMed ID: 63237
[TBL] [Abstract][Full Text] [Related]
11. [The CNS lesion in monkeys spinally infected with the vaccinal poliomyelitis virus].
Tereshkina NV; Lavrova IK; Kozlov VG; Sobolev SG; Tiufanov AV; Koroleva GA; Grigor'eva LV; Chigirinskiĭ AE
Vopr Virusol; 1991; 36(3):222-6. PubMed ID: 1654009
[TBL] [Abstract][Full Text] [Related]
12. International comparison of species of monkey used for the neurovirulence test for oral poliomyelitis vaccine.
Boulger LR; Arya SC; Ahourai P; Marsden SA
J Biol Stand; 1978 Jul; 6(3):233-42. PubMed ID: 102647
[No Abstract] [Full Text] [Related]
13. Morphometric method for evaluating the neurovirulence of live poliomyelitis vaccine.
Tyufanov AV; Stefanov SB
Bull World Health Organ; 1979; 57(5):815-7. PubMed ID: 232013
[TBL] [Abstract][Full Text] [Related]
14. Some aspects of the monkey neurovirulence test used for the assessment of oral poliovirus vaccines.
Furesz J; Contreras G
Dev Biol Stand; 1993; 78():61-70. PubMed ID: 8388832
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of poliovirus type 3 strains after passage through monkey central nervous system.
Jarzabek ZJ; Sadowski W; Janicki P
Acta Virol; 1977 Jan; 21(1):57-62. PubMed ID: 15438
[TBL] [Abstract][Full Text] [Related]
16. The behaviour of Sabin attenuated poliovirus strains in the central nervous system of rhesus monkeys.
Arya SC
J Biol Stand; 1977; 5(4):275-81. PubMed ID: 200628
[No Abstract] [Full Text] [Related]
17. Studies on the characteristics of Poliovirus type 3. III. Strain characteristics after passage in man.
Jarzabek Z; Sadowski W; Kańtoch M; Magrath D; Krawczyński K
Acta Virol; 1976 Oct; 20(5):373-9. PubMed ID: 11664
[TBL] [Abstract][Full Text] [Related]
18. Experimental poliomyelitis in bonnet monkey. Clinical features, virology and pathology.
Samuel BU; Ponnuraj E; Rajasingh J; John TJ
Dev Biol Stand; 1993; 78():71-8. PubMed ID: 8388833
[TBL] [Abstract][Full Text] [Related]
19. Present state and developments in the production of inactivated poliomyelitis vaccine.
van Wezel AL
Dev Biol Stand; 1981; 47():7-13. PubMed ID: 6262162
[TBL] [Abstract][Full Text] [Related]
20. Local antibody response to experimental poliovirus infection in the central nervous system of rhesus monkeys.
Ogra PL; Ogra SS; al-Nakeeb S; Coppola PR
Infect Immun; 1973 Dec; 8(6):931-7. PubMed ID: 4361727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
